According to the report, the Asia Pacific Blood Flow Measurement Devices Market Size is valued at USD 61.46 million in 2020 and is expected to grow at a CAGR of 9.7 % to reach USD 97.64 million by 2025 during the forecast period 2020-2025.
One of the important parts under the diagnostic and research segment in the healthcare sector is the market of Blood flow measurement devices. Numerous diseases and disorders, for example, diabetes and hypertension can cause the supply of blood to the organs to vary which if left untreated can result in organ failure. Significant insights can be gained by measuring blood flow which can then be analyzed to remediate the above-mentioned problems. Changes in blood flow may happen in the early stage of any disease or abnormality.
Rapidly aging population worldwide coupled with the growing prevalence of various vascular disorders is the main driving factor of this market. Cardiac disorders, arterial occlusions, and severe diabetes are other factors contributing to the above-mentioned trend. Costly devices and complex and stringent rules and regulations for companies are a few of the factors that are restricting the growth of this market.
Asia Pacific Blood Flow Measurement Devices Market segmented and sub-segmented into the following categories.
On the basis of region, Asia Pacific has the highest CAGR. Steadily rising geriatric population, high rates of occurrence of non-communicable diseases and the growing focus of industry players in the region are some of the causes which can be attributed to the observable trend mentioned above.
Top Companies leading the Asia Pacific Blood Flow Measurements Devices Market Profiled in the Report are Compumedics Ltd. (Australia), Transonic Systems, Inc. (U.S.), Cook Medical, Inc. (U.S.), Perimed AB (Sweden), Medistim ASA (Norway), ADInstruments (Australia), Deltex Medical Group plc (U.K.), BIOPAC Systems, Inc. (U.S.), Atys Medical (France), SONOTEC Ultraschallsensorik Halle GmbH (Germany), and Moor Instruments Ltd. (U.K.)
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Product
5.1.1 Introduction
5.1.2 Ultrasound
5.1.2.1 Ultrasound Doppler
5.1.2.2 Transit-Time Flow Meters
5.1.3 Laser Doppler
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Non-Invasive Applications
5.2.2.1 Cardiovascular Disease
5.2.2.2 Diabetes
5.2.2.3 Gastroenterology
5.2.2.4 Tumor Monitoring
5.2.2.5 Other Non-Invasive Applications
5.2.3 Invasive Applications
5.2.3.1 CABG
5.2.3.2 Microvascular Surgery
5.2.3.3 Microvascular Surgery
5.2.4 Y-o-Y Growth Analysis, By Application
5.2.5 Market Attractiveness Analysis, By Application
5.2.6 Market Share Analysis, By Application
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Medistim ASA
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Cook Medical, Inc.
8.3 Getinge Group
8.4 Deltex Medical Group PLC
8.5 Transonic Systems, Inc
8.6 Compumedics Limited
8.7 Adinstruments
8.8 Sonotec Ultraschallsensorik Halle GmbH
8.9 Biopac Systems Inc.
8.10 Moor Instruments Ltd.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
